Bone Loss Withdrawn Phase 3 Trials for Progesterone (DB00396)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00827151Bone Mass Accrual in Adolescent AthletesTreatment